Kathleen Manipis

Kathleen Manipis is a Senior Research Fellow at the Centre for Health Economics Research and Evaluation (CHERE) within the Faculty of Health at the University of Technology Sydney. She has been with CHERE since September 2015, initially as a Research Fellow and promoted to Senior Research Fellow in July 2024. Prior to her academic career, she spent 10 years working in the pharmaceutical industry in health economics and clinical research at Covance Australia.

Dr. Manipis specializes in health economics research with a focus on the economic consequences of diseases, particularly foodborne illness and respiratory infections. Her expertise includes:

• Economic evaluation methods for health technologies and pharmaceuticals
• Discrete choice experiments to measure preferences and willingness-to-pay
• Productivity loss measurement and valuation
• Health technology assessment for regulatory bodies
• Pandemic response economic analysis

Her research demonstrates a consistent focus on methodological approaches to economic evaluation, particularly in measuring productivity losses and developing valuation techniques for health states. She has contributed significantly to understanding how different economic evaluation methods impact cost-effectiveness results, with implications for health policy decisions. Her work spans both acute conditions like foodborne illness and chronic conditions with long-term economic impacts, including irritable bowel syndrome, Guillain-Barré syndrome, and other sequelae of infectious diseases.

At CHERE, Dr. Manipis is a key member of the economic evaluation group, providing expert appraisal of pharmaceutical and vaccine industry submissions to the Pharmaceutical Benefits Advisory Committee (PBAC) and health technology assessments for the Medical Services Advisory Committee (MSAC) and Singapore's Agency for Care Effectiveness. She has extensive experience preparing Health Technology Assessment reports for submission to various national health technology assessment bodies.

Dr. Manipis has secured multiple research grants from the Commonwealth Department of Health and Aged Care, the Therapeutic Goods Administration, and the Ministry of Health in Singapore. Her funded research projects demonstrate her expertise in economic evaluation, health technology assessment, and discrete choice methodology, with applications to food safety, pandemic response, and resource allocation decisions.